Hirayama Disease Diagnosed after COVID-19 mRNA Vaccination in an Adolescent Patient: A Case Report
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Hirayama disease is characterized by initially progressive muscular weakness and wasting of the distal upper limbs in young people. It has a male predominance, and its progression spontaneously arrests within several years. Here, we report the case of a 15-year-old girl with findings of Hirayama disease on spinal magnetic resonance imaging (MRI) after she visited the hospital with unilateral muscle weakness that occurred after coronavirus disease 2019 mRNA vaccination. She was asymptomatic for 3 weeks after vaccination; however, starting the night before hospitalization, her right limb began to lose strength. MRI demonstrated typical Hirayama disease findings.
Abstract
Hirayama disease is characterized by initially progressive muscular weakness and wasting of the distal upper limbs in young people. It has a male predominance, and its progression spontaneously arrests within several years. Here, we report the case of a 15-year-old girl with findings of Hirayama disease on spinal magnetic resonance imaging (MRI) after she visited the hospital with unilateral muscle weakness that occurred after coronavirus disease 2019 mRNA vaccination. She was asymptomatic for 3 weeks after vaccination; however, starting the night before hospitalization, her right limb began to lose strength. MRI demonstrated typical Hirayama disease findings.
참고문헌 (10)
- Hirayama K, "Juvenile muscular atrophy of distal upper extremity(Hirayama disease)", Intern Med, 39, pp.283~290 (2000)
- Hirayama K, "Juvenile muscular atrophy of distal upper extremity (Hirayama disease): focal cervical ischemic poliomyelopathy", Neuropathology, 20(Suppl), pp.S91~S94 (2000)
- Finsterer J, "Neurological side effects of SARS-CoV-2 vaccinations", Acta Neurol Scand, 145, pp.5~9 (2022)
- Joob B, "Expected viscosity after COVID-19 vaccination, hyperviscosity and previous COVID-19", Clin Appl Thromb Hemost, 27, pp.10760296211020833~ (2021)
- Jeong S, "Seven-month analysis of five SARS-CoV-2 antibody assay results after ChAdOx1 nCoV-19 vaccination : significant decrease in SARS-CoV-2 antibody titer", Diagnostics(Basel), 12, pp.85~ (2021)
- Huang YL, "Chen CJ : Hirayama disease", Neuroimaging Clin N Am, 21, pp.939~950 (2011)
- Jung Phil Huh, "Clinical Characteristics, Electrodiagnostic, and Imaging Findings of Atypical Forms of Motor Neuron Disease", Annals of Rehabilitation Medicine, 34(6), pp.701~709 (2010), 대한재활의학회
- Nagaoka M, "Electromyographic analysis on juvenile muscular atrophy of unilateral upper extremity (author's transl)", No To Shinkei, 32, pp.821~828 (1980)
- Shizukawa H, "Cervical flexion-induced changes of motor evoked potentials by transcranial magnetic stimulation in a patient with Hirayama disease--juvenile muscular atrophy of unilateral upper extremity", Rinsho Shinkeigaku, 34, pp.500~503 (1994)
- Weber F, "Flexion myelopathy : Hirayama's syndrome", J Neurol, 259, pp.567~568 (2012)